Active Moderate To Severe Ted clinical trials

Explore recruiting active moderate to severe ted clinical trials.

Recruiting active moderate to severe ted studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Active Moderate To Severe Ted trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Interventional, open-label, single-group, long-term follow-up trial of Lu AG22515 in patients with moderate-to-severe Thyroid Eye Disease

Poland, Bulgaria, Germany, Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Active Moderate To Severe Ted trials by city

Active Moderate To Severe Ted in Toronto Active Moderate To Severe Ted in Vancouver Active Moderate To Severe Ted in Montreal Active Moderate To Severe Ted in Calgary Active Moderate To Severe Ted in Edmonton Active Moderate To Severe Ted in Ottawa Active Moderate To Severe Ted in Winnipeg Active Moderate To Severe Ted in Quebec City Active Moderate To Severe Ted in Hamilton Active Moderate To Severe Ted in Kitchener Active Moderate To Severe Ted in London Active Moderate To Severe Ted in Halifax Active Moderate To Severe Ted in New York Active Moderate To Severe Ted in Los Angeles Active Moderate To Severe Ted in Chicago Active Moderate To Severe Ted in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease